Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-10-016607)

Filing Details

Accession Number:: 0001209191-10-016607
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-03-12 12:00:00
Reporting Period:: 2010-03-12

Filing Date:: 2010-03-12
Accepted Time:: 2010-03-12 16:03:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1008848	Acorda Therapeutics Inc	ACOR	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1176268	Phd Sandra Panem	15 Skyline Drive Hawthorne NY 10532		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-03-12	8,394	$35.01	352,452	No	4	S	Indirect	Cross Atlantic

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Cross Atlantic

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,630	Direct

Footnotes

Includes 309,188 shares beneficially owned by Cross Atlantic Partners IV, K/S and 43,264 shares owned by Nordea Bank Danmark, A/S. Sandra Panem, PhD, is a partner of Cross Atlantic Partners and exercises voting and investment power over these shares. Dr. Panem disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.